RBC Capital Mkts has recently reduced Outset Medical Inc (OM) stock to Sector Perform rating, as announced on August 8, 2024, according to Finviz. Earlier, on June 21, 2024, RBC Capital Mkts had raised the stock from a Sector Perform to Outperform, setting a price target of $6. for OM stock. BTIG Research also initiated Buy rating with a price target of $6. Additionally, CL King raised Buy rating on April 5, 2024, with a target price of $6. RBC Capital Mkts analysts, in their report published on January 12, 2024, also reduced Sector Perform rating and set a price target of $14 for Outset Medical Inc’s stock. Analyst ratings are significant because they provide insights into stock performance expectations, influencing investor decisions and market sentiment.
Sponsored
Outset Medical Inc (OM) Stock Trading Recap
On Wednesday, Outset Medical Inc (OM) stock saw a modest uptick, ending the day at $0.65 which represents a slight increase of $0.12 or 22.64% from the prior close of $0.53. The stock opened at $0.52 and touched a low of $0.5 during the day, reaching a high of $0.65. The volume of shares traded was 2.20 million exceeding the average volume of 2.05 million.
OM Stock Performance and Moving Averages
In recent trading, Outset Medical Inc (OM) stock price has shown some volatility, fluctuating 27.45% over the last five trades and 4.96% over the past 30 trades. This represents a notable shift from earlier in the year. Over the last six months, the stock has risen by -71.11%, and it has plunged by -82.14% in the previous three months. Currently, OM is trading at 14.88%, -68.44%, and -80.09% relative to its 20-Day, 50-Day, and 200-Day Simple Moving Averages, respectively.
As of the latest trading close, OM, a Healthcare sector stock, is trading -94.78% below its 52-week high but remains 49.42% above its 52-week low. The Average True Range (ATR) (14 days) of 0.12 highlights the stock’s average volatility, providing insight into how much the price typically fluctuates. This measure is crucial for understanding potential price swings and assessing overall market risk.
Outset Medical Inc’s Profitability and Valuation Ratios
Outset Medical Inc’s profitability metrics reveal strong financial health. The company currently boasts an operating margin of -129.25% and a profit margin of -136.72%, with a gross margin of -71.11%. The profit margin, also known as the revenue ratio or gross profit ratio, measures how efficiently a company converts sales into net income; higher margins indicate greater profitability.
In terms of valuation, Outset Medical Inc’s market capitalization stands at $33.86 million. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s market value. Additionally, the Price-to-Sales Ratio is 0.29, reflecting the market’s valuation of the company’s sales, while the Price-to-Book Ratio is 0.49, comparing the market value to the company’s book value.
Understanding Insider Trading
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 8.27% of Outset Medical Inc (OM)’s shares, while financial institutions hold 96.13%.
Notable insider trades include GROSSMAN D KEITH, Director at Outset Medical Inc (OM), who sold 38117 shares on Jun 03 ’24, at $3.78 each, totaling $0.14 million. On Jan 16 ’24, Nash Marc, SVP Operations and R&D, sold 678 shares for $429 each, amounting to $0.29 million.
